{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T11:38:31Z","timestamp":1779363511997,"version":"3.53.0"},"reference-count":67,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Breast cancer is the most commonly diagnosed cancer among women, with approximately one in eight women developing the disease during their lifetime. Despite advancements in current treatment options, breast cancer was responsible for an estimated 670,000 deaths worldwide in 2022. This highlights the urgent need for the development of novel therapeutic strategies. Historically, plant-derived compounds have played a significant role in cancer therapy, exemplified by widely used chemotherapeutic agents such as paclitaxel and docetaxel. In recent years, increasing attention has been directed toward novel plant-derived compounds as potential anti-cancer agents. Among these, Naringenin, a flavonoid predominantly found in citrus fruits, has shown promising antioxidant, anti-inflammatory, and anti-cancer properties. This review highlights recent studies investigating the effects of Naringenin and its derivatives on breast cancer. Evidence from both in vitro and in vivo animal models suggests that Naringenin may exert anti-tumor activity by inhibiting cell proliferation, promoting apoptosis, modulating key cell signaling pathways, and enhancing radio-sensitivity in breast cancer cells. Although preclinical evidence strongly supports the anticancer potential of Naringenin in breast cancer, comprehensive clinical studies are urgently needed to validate its efficacy and safety in humans.<\/jats:p>","DOI":"10.3390\/biom16030480","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:07:06Z","timestamp":1774271226000},"page":"480","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of Naringenin in Preclinical Models of Breast Cancer"],"prefix":"10.3390","volume":"16","author":[{"given":"Emily C.","family":"Irwin","sequence":"first","affiliation":[{"name":"Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-1687","authenticated-orcid":false,"given":"Newman Siu Kwan","family":"Sze","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4218-5851","authenticated-orcid":false,"given":"Evangelia","family":"Tsiani","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Faculty of Applied Health Sciences, Brock University, St. Catharines, ON L2S 3A1, Canada"},{"name":"Centre for Bone and Muscle Health, Brock University, St. Catharines, ON L2S 3A1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"ref_1","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","unstructured":"(2026, March 10). Canadian Cancer Society Breast Cancer Statistics. Available online: https:\/\/cancer.ca\/en\/cancer-information\/cancer-types\/breast\/statistics."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s12032-023-02111-9","article-title":"Extensive Review on Breast Cancer Its Etiology, Progression, Prognostic Markers, and Treatment","volume":"40","author":"Swaminathan","year":"2023","journal-title":"Med. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Carvalho, E., Canberk, S., Schmitt, F., and Vale, N. (2025). Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies. Cancers, 17.","DOI":"10.3390\/cancers17071102"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e20200024","DOI":"10.29289\/25945394202020200024","article-title":"Histological and Molecular Classification of Breast Cancer: What Do We Know?","volume":"30","author":"Nascimento","year":"2020","journal-title":"Mastology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast Cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","article-title":"Breast Cancer: Pathogenesis and Treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/bcr3039","article-title":"Mutations in the Phosphatidylinositol 3-Kinase Pathway: Role in Tumor Progression and Therapeutic Implications in Breast Cancer","volume":"13","author":"Miller","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Karagiannakos, A., Adamaki, M., Tsintarakis, A., Vojtesek, B., F\u00e5hraeus, R., Zoumpourlis, V., and Karakostis, K. (2022). Targeting Oncogenic Pathways in the Era of Personalized Oncology: A Systemic Analysis Reveals Highly Mutated Signaling Pathways in Cancer Patients and Potential Therapeutic Targets. Cancers, 14.","DOI":"10.3390\/cancers14030664"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gali\u00e8, M. (2019). RAS as Supporting Actor in Breast Cancer. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01199"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Raheem, F., Karikalan, S.A., Batalini, F., El Masry, A., and Mina, L. (2023). Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242216198"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1018773123899","article-title":"Bcl-2 Gene Family and Related Proteins in Mammary Gland Involution and Breast Cancer","volume":"4","author":"Schorr","year":"1999","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-018-0797-x","article-title":"Receptor Tyrosine Kinases (RTKs) in Breast Cancer: Signaling, Therapeutic Implications and Challenges","volume":"17","author":"Butti","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1055\/s-0030-1249898","article-title":"Metabolomics: A Tool for Anticancer Lead-Finding from Natural Products","volume":"76","author":"Kim","year":"2010","journal-title":"Planta Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1021\/np068054v","article-title":"Natural Products as Sources of New Drugs over the Last 25 Years","volume":"70","author":"Newman","year":"2007","journal-title":"J. Nat. Prod."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.nut.2016.03.020","article-title":"Prenylated Chalcones and Flavonoids for the Prevention and Treatment of Cancer","volume":"32","author":"Venturelli","year":"2016","journal-title":"Nutrition"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Shilpa, V., Shams, R., Dash, K.K., Pandey, V.K., Dar, A.H., Ayaz Mukarram, S., Hars\u00e1nyi, E., and Kov\u00e1cs, B. (2023). Phytochemical Properties, Extraction, and Pharmacological Benefits of Naringin: A Review. Molecules, 28.","DOI":"10.3390\/molecules28155623"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Elsori, D., Pandey, P., Ramniwas, S., Kumar, R., Lakhanpal, S., Rab, S.O., Siddiqui, S., Singh, A., Saeed, M., and Khan, F. (2024). Naringenin as Potent Anticancer Phytocompound in Breast Carcinoma: From Mechanistic Approach to Nanoformulations Based Therapeutics. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1406619"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2011.06.024","article-title":"Dietary Flavones and Flavonones Display Differential Effects on Aromatase (CYP19) Transcription in the Breast Cancer Cells MCF-7","volume":"344","author":"Li","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/iub.1049","article-title":"The Naringenin-induced Proapoptotic Effect in Breast Cancer Cell Lines Holds out against a High Bisphenol a Background","volume":"64","author":"Bulzomi","year":"2012","journal-title":"IUBMB Life"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"732980","DOI":"10.1155\/2014\/732980","article-title":"Cytotoxic Activities against Breast Cancer Cells of Local Justicia Gendarussa Crude Extracts","volume":"2014","author":"Ayob","year":"2014","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12935-015-0194-0","article-title":"Growth Inhibitory and Chemo-Sensitization Effects of Naringenin, a Natural Flavanone Purified from Thymus Vulgaris, on Human Breast and Colorectal Cancer","volume":"15","author":"Abaza","year":"2015","journal-title":"Cancer Cell Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2016.07.007","article-title":"Hesperetin and Naringenin Sensitize HER2 Positive Cancer Cells to Death by Serving as HER2 Tyrosine Kinase Inhibitors","volume":"160","author":"Chandrika","year":"2016","journal-title":"Life Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopen.2016.09.004","article-title":"Inhibition of the MAPK Pathway Alone Is Insufficient to Account for All of the Cytotoxic Effects of Naringenin in MCF-7 Breast Cancer Cells","volume":"3","author":"Eanes","year":"2016","journal-title":"Biochim. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-016-0698-0","article-title":"Naringenin Prevents TGF-\u03921 Secretion from Breast Cancer and Suppresses Pulmonary Metastasis by Inhibiting PKC Activation","volume":"18","author":"Zhang","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1600934","DOI":"10.1002\/mnfr.201600934","article-title":"Citrus Flavonoid Naringenin Reduces Mammary Tumor Cell Viability, Adipose Mass, and Adipose Inflammation in Obese Ovariectomized Mice","volume":"61","author":"Ke","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6040149","DOI":"10.1155\/2018\/6040149","article-title":"Identification of Estrogen Receptor \u03b1 Antagonists from Natural Products via In Vitro and In Silico Approaches","volume":"2018","author":"Pang","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10787-018-00556-3","article-title":"Naringenin Inhibits Migration of Breast Cancer Cells via Inflammatory and Apoptosis Cell Signaling Pathways","volume":"27","author":"Zhao","year":"2019","journal-title":"Inflammopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41523-020-00178-5","article-title":"DAXX-Inducing Phytoestrogens Inhibit ER+ Tumor Initiating Cells and Delay Tumor Development","volume":"6","author":"Peiffer","year":"2020","journal-title":"npj Breast Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jsps.2020.12.002","article-title":"Identification of Potential Therapeutic Target of Naringenin in Breast Cancer Stem Cells Inhibition by Bioinformatics and in Vitro Studies","volume":"29","author":"Hermawan","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1038\/s41598-021-86599-z","article-title":"Anti-Estrogenic and Anti-Aromatase Activities of Citrus Peels Major Compounds in Breast Cancer","volume":"11","author":"Ezzat","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.14715\/cmb\/2021.67.2.2","article-title":"Naringenin Inhibits Human Breast Cancer Cells (MDA-MB-231) by Inducing Programmed Cell Death, Caspase Stimulation, G2\/M Phase Cell Cycle Arrest and Suppresses Cancer Metastasis","volume":"67","author":"Qi","year":"2021","journal-title":"Cell. Mol. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Xiong, H., Chen, Z., Lin, B., Xie, B., Liu, X., Chen, C., Li, Z., Jia, Y., Wu, Z., and Yang, M. (2022). Naringenin Regulates FKBP4\/NR3C1\/NRF2 Axis in Autophagy and Proliferation of Breast Cancer and Differentiation and Maturation of Dendritic Cell. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.745111"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"110927","DOI":"10.1016\/j.cbi.2024.110927","article-title":"Evaluating Flavonoids as Potential Aromatase Inhibitors for Breast Cancer Treatment: In Vitro Studies and in Silico Predictions","volume":"392","author":"Seo","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Santana, M.R.D., Santos, Y.B.D., Santos, K.S., Santos Junior, M.C., Victor, M.M., Ramos, G.D.S., Nascimento, R.P.D., and Costa, S.L. (2024). Differential Interactions of Flavonoids with the Aryl Hydrocarbon Receptor In Silico and Their Impact on Receptor Activity In Vitro. Pharmaceuticals, 17.","DOI":"10.3390\/ph17080980"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"23744","DOI":"10.1039\/D4RA03832K","article-title":"In Silico Evaluation of Potential Breast Cancer Receptor Antagonists from GC-MS and HPLC Identified Compounds in Pleurotus ostreatus Extracts","volume":"14","author":"Effiong","year":"2024","journal-title":"RSC Adv."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e14604","DOI":"10.1111\/cbdd.14604","article-title":"Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments","volume":"104","author":"Wu","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jare.2022.06.006","article-title":"Naringenin in Si-Ni-San Formula Inhibits Chronic Psychological Stress-Induced Breast Cancer Growth and Metastasis by Modulating Estrogen Metabolism through FXR\/EST Pathway","volume":"47","author":"Zhang","year":"2023","journal-title":"J. Adv. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2009.08.005","article-title":"Prenylation Has a Compound Specific Effect on the Estrogenicity of Naringenin and Genistein","volume":"118","author":"Kretzschmar","year":"2010","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Filho, J.C.C., Sarria, A.L.F., Becceneri, A.B., Fuzer, A.M., Batalh\u00e3o, J.R., Da Silva, C.M.P., Carlos, R.M., Vieira, P.C., Fernandes, J.B., and Cominetti, M.R. (2014). Copper (II) and 2,2\u2032-Bipyridine Complexation Improves Chemopreventive Effects of Naringenin against Breast Tumor Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107058"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jinorgbio.2015.04.011","article-title":"Insights into the Mechanisms Underlying the Antitumor Activity of an Oxidovanadium(IV) Compound with the Antioxidant Naringenin. Albumin Binding Studies","volume":"149","author":"Islas","year":"2015","journal-title":"J. Inorg. Biochem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.apjtb.2016.08.004","article-title":"Cytotoxic, Genotoxic and Apoptotic Effects of Naringenin-Oxime Relative to Naringenin on Normal and Cancer Cell Lines","volume":"6","author":"Kocyigit","year":"2016","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Latif, A.D., Gonda, T., V\u00e1gv\u00f6lgyi, M., K\u00fasz, N., Kulm\u00e1ny, \u00c1., Ocsovszki, I., Zomborszki, Z.P., Zupk\u00f3, I., and Hunyadi, A. (2019). Synthesis and In Vitro Antitumor Activity of Naringenin Oxime and Oxime Ether Derivatives. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20092184"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1800016","DOI":"10.1002\/cbdv.201800016","article-title":"Synthesis, Cancer-Selective Antiproliferative and Apoptotic Effects of Some (\u00b1)-Naringenin Cycloaminoethyl Derivatives","volume":"15","author":"Zaim","year":"2018","journal-title":"Chem. Biodivers."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1080\/03639045.2018.1496445","article-title":"Augmented Anticancer Activity of Naringenin-Loaded TPGS Polymeric Nanosuspension for Drug Resistive MCF-7 Human Breast Cancer Cells","volume":"44","author":"Rajamani","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/TUB-211506","article-title":"Breast Cancer Suppression by Curcumin-Naringenin-Magnetic-Nano-Particles: In Vitro and in Vivo Studies","volume":"43","author":"Askar","year":"2021","journal-title":"Tumor Biol."},{"key":"ref_47","first-page":"100022","article-title":"Biodegradable Nanoparticulate Co-Delivery of Flavonoid and Doxorubicin: Mechanistic Exploration and Evaluation of Anticancer Effect in Vitro and in Vivo","volume":"3","author":"Khan","year":"2021","journal-title":"Biomater. Biosyst."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"103552","DOI":"10.1016\/j.jddst.2022.103552","article-title":"Anti-Cancer Activity of Naringenin Loaded Smart Polymeric Nanoparticles in Breast Cancer","volume":"74","author":"Acet","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Hao, Y., Wei, Z., Wang, Z., Li, G., Yao, Y., and Dun, B. (2021). Biotransformation of Flavonoids Improves Antimicrobial and Anti-Breast Cancer Activities In Vitro. Foods, 10.","DOI":"10.3390\/foods10102367"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/bab.2399","article-title":"Fabrication of Bovine Serum Albumin-polyethylene Glycol Nanoparticle Conjugated-folic Acid Loaded-naringenin as an Efficient Carrier Biomacromolecule for Suppression of Cancer Cells","volume":"70","author":"Firouzabadi","year":"2023","journal-title":"Biotechnol. Appl. Biochem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12032-023-02227-y","article-title":"Chitosan-Encapsulated Naringenin Promotes ROS Mediated through the Activation of Executioner Caspase-3","volume":"41","author":"Jaganathan","year":"2023","journal-title":"Med. Oncol."},{"key":"ref_52","first-page":"e58634","article-title":"In-Vitro Cytotoxicity, Apoptotic Property, and Gene Expression Changes Induced by Naringenin-7-O-Glucoside in Triple-Negative Breast Cancer","volume":"16","author":"James","year":"2024","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3786627","DOI":"10.1049\/2024\/3786627","article-title":"Liposomal-Naringenin Radiosensitizes Triple-Negative Breast Cancer MDA-MB-231 Cells In Vitro","volume":"2024","author":"Pearce","year":"2024","journal-title":"IET Nanobiotechnol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yexcr.2014.05.017","article-title":"A Naringenin\u2013Tamoxifen Combination Impairs Cell Proliferation and Survival of MCF-7 Breast Cancer Cells","volume":"327","author":"Hatkevich","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_55","first-page":"122","article-title":"Naringenin Enhances the Anti-Cancer Effect of Cyclophosphamide against MDA-MB-231 Breast Cancer Cells Via Targeting the STAT3 Signaling Pathway","volume":"19","author":"Noori","year":"2020","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"173725","DOI":"10.1016\/j.ejphar.2020.173725","article-title":"Combining Naringenin and Metformin with Doxorubicin Enhances Anticancer Activity against Triple-Negative Breast Cancer in Vitro and in Vivo","volume":"891","author":"Pateliya","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zhang, Y.-Z., Yang, J.-Y., Wu, R.-X., Fang, C., Lu, H., Li, H.-C., Li, D.-M., Zuo, H.-L., Ren, L.-P., and Liu, X.-Y. (2021). Network Pharmacology\u2013Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.714628"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13058-023-01641-4","article-title":"PKC-\u03b6 Mediated Reduction of the Extracellular Vesicles-Associated TGF-\u03921 Overcomes Radiotherapy Resistance in Breast Cancer","volume":"25","author":"Zhang","year":"2023","journal-title":"Breast Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tox.2018.08.013","article-title":"Combinatorial Anti-Proliferative Effects of Tamoxifen and Naringenin: The Role of Four Estrogen Receptor Subtypes","volume":"410","author":"Xu","year":"2018","journal-title":"Toxicology"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Ajji, P.K., Walder, K., and Puri, M. (2020). Combination of Balsamin and Flavonoids Induce Apoptotic Effects in Liver and Breast Cancer Cells. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.574496"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Rhman, M.A., Devnarain, N., Khan, R., and Owira, P.M.O. (2022). Synergism Potentiates Oxidative Antiproliferative Effects of Naringenin and Quercetin in MCF-7 Breast Cancer Cells. Nutrients, 14.","DOI":"10.3390\/nu14163437"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"7489","DOI":"10.1007\/s11033-023-08664-2","article-title":"Naringenin in Combination with Quercetin\/Fisetin Shows Synergistic Anti-Proliferative and Migration Reduction Effects in Breast Cancer Cell Lines","volume":"50","author":"Shahbazi","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s13238-011-1056-8","article-title":"Naringenin Reduces Lung Metastasis in a Breast Cancer Resection Model","volume":"2","author":"Qin","year":"2011","journal-title":"Protein Cell"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jnutbio.2011.07.003","article-title":"The Citrus Flavonone Hesperetin Inhibits Growth of Aromatase-Expressing MCF-7 Tumor in Ovariectomized Athymic Mice","volume":"23","author":"Ye","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00210-021-02104-3","article-title":"Enhanced Antitumor Activity of Doxorubicin by Naringenin and Metformin in Breast Carcinoma: An Experimental Study","volume":"394","author":"Pateliya","year":"2021","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Noori, S., Nourbakhsh, M., Imani, H., Deravi, N., Salehi, N., and Abdolvahabi, Z. (2022). Naringenin and Cryptotanshinone Shift the Immune Response towards Th1 and Modulate T Regulatory Cells via JAK2\/STAT3 Pathway in Breast Cancer. BMC Complement. Med. Ther., 22.","DOI":"10.1186\/s12906-022-03625-x"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Jastrz\u0119bska, M., Giebu\u0142towicz, J., Ciechanowicz, A.K., Wrzesie\u0144, R., Bielecki, W., and Bobrowska-Korczak, B. (2023). Effect of Polyphenols and Zinc Co-Supplementation on the Development of Neoplasms in Rats with Breast Cancer. Foods, 12.","DOI":"10.3390\/foods12020356"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/3\/480\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:33:33Z","timestamp":1774272813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/3\/480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["biom16030480"],"URL":"https:\/\/doi.org\/10.3390\/biom16030480","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]}}}